- Conditions
- Tinea Pedis, Athlete's Foot
- Interventions
- NAFT-500, Placebo 2-weeks, Naftin 1%, Placebo 4-weeks
- Drug
- Lead sponsor
- Merz North America, Inc.
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 707 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2009
- U.S. locations
- 17
- States / cities
- Birmingham, Alabama • Los Angeles, California • San Francisco, California + 13 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–3
of 3
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Tinea Pedis, Tinea Cruris
- Interventions
- NAFT500 (pediatric), NAFT600 (pediatric), NAFT500 (adult), NAFT600 (adult)
- Drug
- Lead sponsor
- Merz North America, Inc.
- Industry
- Eligibility
- 12 Years to 65 Years
- Enrollment
- 56 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 2
- States / cities
- Austin, Texas • College Station, Texas
- Conditions
- Tinea Cruris, Jock Itch
- Interventions
- NAFT-500, Placebo
- Drug
- Lead sponsor
- Merz North America, Inc.
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 334 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2010
- U.S. locations
- 15
- States / cities
- Birmingham, Alabama • San Diego, California • San Francisco, California + 12 more